AbbVie, Inc.

AbbVie is a global biopharmaceutical company that focuses on the discovery, development, and commercialization of advanced therapies. Established in 2013 as a spin-off from Abbott Laboratories, AbbVie specializes in a range of therapeutic areas, including immunology, oncology, neuroscience, and virology. The company is known for its commitment to research and innovation, aiming to address complex health challenges and improve patient outcomes. AbbVie operates worldwide, leveraging its scientific expertise and collaborative partnerships to bring new treatments to market. The company also emphasizes the importance of patient support and education, ensuring that individuals have access to the resources they need to manage their health effectively. This data was scraped from IndustryNet.com